San Diego, CA 9/2/14—BioLegend acquired on August 29 the Antibody Services business unit of Covance for an undisclosed amount. The business develops and manufactures antibodies and research reagents for neuroscience, immunopathology, cell biology, epitope tags and immunohistochemistry detection, including IVD antibodies for immunohistochemistry (IHC). “The addition of Neuroscience and IHC antibody tools to our catalog means accelerated discovery for our current and new customers. We also hope to bring our well-known quality, support, and value in the immunology community to neuroscience researchers worldwide,” said BioLegend President and CEO Gene Lay.